{"SPADE_N_15875": {"Sequence Information": {"Peptide Name": "Brevinin CTcu5", "Sequence": "LIAGLAANFLPQILCKIARKC", "Sequence Length": 21, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Clinotarsus curtipes\n2. Odorrana andersonii\n3. Odorrana grahami", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "E3SYG2", "uniprotUrl": "http://www.uniprot.org/uniprot/E3SYG2", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}, {"uniprotId": "D2K8D1", "uniprotUrl": "http://www.uniprot.org/uniprot/D2K8D1", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}, {"uniprotId": "C3RTH8", "uniprotUrl": "http://www.uniprot.org/uniprot/C3RTH8", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Novel antibacterial peptides from the skin secretion of the Indian bicoloured frog Clinotarsus curtipes.", "Pubmed ID": "24161537", "Reference": "Biochimie. 2014;97:144-151", "Author": "Abraham P, George S, Kumar K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24161537"}, {"Title": "Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides.", "Pubmed ID": "25997127", "Reference": "PLoS One. 2015;10:e0124210", "Author": "Abraham P, Sundaram A, R A, V R, George S, Kumar K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25997127"}, {"Title": "B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity.", "Pubmed ID": "32679168", "Reference": "Peptides. 2020;132:170373", "Author": "Abraham P, Jose L, Maliekal TT, Kumar RA, Kumar K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32679168"}], "Mass": 2256.82, "PI": 9.5, "Net Charge": 3, "Hydrophobicity": 1.07, "Frequent Amino Acids": "ALI", "Absent Amino Acids": "DEHMOSTUVWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 7, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_N_15875", "Similar Sequences": [{"SPADE_ID": "SPADE_N_01700", "Similarity": 1.0, "Sequence": "FFPLIAGLAANFLPQILCKIARKC"}, {"SPADE_ID": "SPADE_UN_12434", "Similarity": 1.0, "Sequence": "LIAGLAANFLPQILCKIARKC"}, {"SPADE_ID": "SPADE_UN_15854", "Similarity": 1.0, "Sequence": "LIAGLAANFLPQILCKIARKC"}], "Hemolytic Activity": "Rabbit erythrocytes:38% Hemolysis=200 µg/ml,Human erythrocytes:40% Hemolysis=200 µg/ml,Human embryonic kidney HEK293 cells:50% Cytotoxicity=>100 µg/ml,Human PBMC:50% Cytotoxicity=75.1±1.46 µg/ml", "Target Organism": "Staphylococcus aureus MTCC 9542(MIC=>100µg/ml),Bacillus subtilis MTCC 14416(MIC=50µg/ml),Bacillus coagulans ATCC 7050(MIC=6.25-15µg/ml),Enterococcus faecalis ATCC 29212(MIC=100µg/ml),Staphylococcus aureus ATCC 43300(MIC=>100µg/ml),Escherichia coli MG1655(MIC=7-25µg/ml),Vibrio cholerae(MIC=15-25µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>100µg/ml),Human epidermoid carcinoma A431(50-60% Cytotoxicity=>100µg/ml),Mycobacterium tuberculosis H37Rv(MIC=12.5±0.5µg/ml),Mycobacterium smegmatis NCIM 5138(no activity data),Human acute monocytic leukemia THP-1(no activity data)"}}}